Boston Scientific Deep Brain Stimulation

Boston Scientific's Vercise™ Neural Navigator 5 (VN5) Software has received CE mark! The VN5 software allows clinicians to personalise Deep Brain Stimulation (DBS) therapy with unparalleled precision, providing enhanced imaging and streamlined programming. 📰 Read the press release here: https://lnkd.in/dZa78RDv #BSCEMEA #DeepBrainStimulation #DBS #VN5 #ImageGuidedProgramming

Questa settimana si è tenuta un’iniziativa molto importante per i pazienti e le famiglie che affrontano la malattia di Parkinson. “Swim for Parkinson's”, attività organizzata da Fondazione Limpe, ha infatti visto 30 nuotatori attraversare lo Stretto di Messina, con l’obiettivo di sensibilizzare il pubblico e raccogliere fondi per continuare ad avanzare progresso e ricerca su questa malattia. A questo appuntamento hanno preso parte anche alcuni #BSCEmployees che, insieme a Vincent Sourdaine - Vicepresidente EMEA di Neuromodulazione, hanno nuotato con persone con Parkinson, familiari e neurologi, per sottolineare l'importanza dell'attività fisica e del sostegno da parte della comunità. In Boston Scientific Italia, siamo orgogliosi di sostenere questa iniziativa e ringraziamo Fondazione Limpe (Società LIMPE-DISMOV) per il coinvolgimento, e i nostri dipendenti per la loro partecipazione attiva.

We successfully concluded our session with PD Dr. Philipp Capetian and Gregg Malarde, Product Manager from our #DBS team, at the Deep Brain Stimulation Society Congress. They presented on optimizing clinical practice and research in deep brain stimulation. Thank you to all participants for your attention. We're grateful to support you in every step of your DBS journey. For those who couldn't attend, visit our DBS Visualization Therapy page to learn more: https://lnkd.in/dp6jV8-Q #BSCEMEA #DeepBrainStimulation #ImageGuidedProgramming

📅 Plan your visit to the 2024 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting this June 1-4 in Nashville, Tennessee. Catch Boston Scientific’s poster presentations below, and meet us at booth #201 to discuss our latest innovations in Deep Brain Stimulation and Image Guided Programming with Brainlab. Learn more: https://lnkd.in/ekVrQCG5 #ASSFN

#ASSFN2024 is just around the corner! Join our lunch symposium on June 2 to learn about biologically inspired pallidal burst stimulation for Parkinson’s Disease, presented by Nader Pouratian, MD, PhD, Professor and Chair of the Department of Neurological Surgery, UT Southwestern Medical Center. We look forward to seeing you there!  📅 Mark your calendar: https://lnkd.in/g_ZVK6Cp  American Society for Stereotactic and Functional Neurosurgery

Will we be seeing you at the International Neuromodulation Society 16th World Congress this weekend? Stop by our booth to discuss Boston Scientific’s Vercise Genus™ DBS System and our latest innovations in Image Guided Programming. In the meantime, browse our #INS2024 schedule to see what else we have planned: https://lnkd.in/gm3HhjNM

Join us live at #INS2024 to explore our latest innovations to help expand access to care and treat more patients. Don’t miss our poster presentations for a deeper dive into the latest data surrounding DBS therapy. 📅 Mark your calendar! https://lnkd.in/gm3HhjNM International Neuromodulation Society

📢 The International Neuromodulation Society 16th World Congress is almost here! We’re excited to discuss the Vercise Genus™ DBS System and Image Guided Programming live with our global peers. Visit our booth to connect with the Boston Scientific team, and don’t miss our #INS2024 presentations: https://lnkd.in/gm3HhjNM

Stay informed on the latest advancements in Deep Brain Stimulation (DBS) therapy. For the most treatment options available* without compromise, look no further than the Vercise Genus™ DBS System. With more than 25,000 patients implanted worldwide and 10 years of proven performance¹, Boston Scientific has a battery you can depend on. No two PD patients are alike. See DBS from every angle with Boston Scientific’s latest innovation in Image Guided Programming, the Vercise™ Neural Navigator 5 (VN5) System, offering an easier and more efficient way to personalize your patient’s DBS journey. Explore DBS and personalized treatment for optimal symptom relief: https://lnkd.in/gnKak-bf Learn how you can personalize your patient’s DBS journey: https://lnkd.in/gJBdW-Ys * Information for competitive devices excerpted from the literature published by Medtronic (M982261A015 Rev A, M017563C002 Rev A, M939241A051 Rev A, M927170A073 Rev A, M017562C002 Rev A, M982097A013 Rev A) and Abbott (ARTEN600150429 - B, ARTEN600102238 - A, ARTEN600266398 -A), and 1. Boston Scientific data on file. Schüpbach, Michael & Chabardes, Stephan & Matthies, Cordula & Pollo, Claudio & Steigerwald, Frank & Timmermann, Lars & Vandewalle, Veerle & Volkmann, Jens & Schuurman, P.. (2017). Directional leads for deep brain stimulation: Opportunities and challenges. Movement Disorders. 32. 10.1002/mds.27096. Steffen, J. K., Reker, P., Mennicken, F. K., Dembek, T. A., Dafsari, H. S., Fink, G. R., Visser-Vandewalle, V., & Barbe, M. T. (2020). Bipolar Directional Deep Brain Stimulation in Essential and Parkinsonian Tremor. Neuromodulation: Technology at the Neural Interface, 23(4), 543–549. DOI: 10.1111/ner.13109 Reker, P., Dembek, T. A., Becker, J., Visser-Vandewalle, V., & Timmermann, L. (2016). Directional deep brain stimulation: A case of avoiding dysarthria with bipolar directional current steering. Parkinsonism & Related Disorders, 31, 156-158. https://lnkd.in/gUbg6avW Kirsch, A. D., Hassin-Baer, S., Matthies, C., Volkmann, J., & Steigerwald, F. (2018). Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism & Related Disorders, 55, 61-67. https://lnkd.in/gm5Bf7Kz. Boston Scientific (Vercise ™ Neural Navigator 5 Software Programming Manual MP92736308-01).

Parkinson’s Disease (PD) can affect people of all ages. Although it is more commonly diagnosed in people over the age of 60, about 10% of people have early-onset or young-onset disease, which begins before age 50.¹ ² Boston Scientific’s Deep Brain Stimulation system is designed to be tailored to your patients’ lifestyle. Learn more: https://lnkd.in/gpVffH4M 1. https://lnkd.in/g4KFCvfn 2. https://lnkd.in/g7MCikbh #PDAwarenessMonth